Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell).
NCT06654700
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
1200
Enrollment
INDUSTRY
Sponsor class
Conditions
Herpes Zoster
Interventions
BIOLOGICAL:
Recombinant Zoster Vaccine (CHO Cell)
Sponsor
MAXVAX Biotechnology Limited Liability Company